Psychosocial Impact of Chronic Infection with Hepatitis B Virus on British Patients

Overview

Journal Genitourin Med

Specialty Infectious Diseases

Date 1985 Aug 1

PMID 4018808

Citations 9

Authors

A S Lok

D J van Leeuwen

H C Thomas

S Sherlock

Affiliations

Soon will be listed here.

Abstract

The effects of chronic infection with hepatitis B virus (HBV) on the lives of 40 British patients were studied by means of a questionnaire. The aspects considered were: social, sexual, and family life, physical and psychological health, and work. Thirty six patients considered their lives to have been affected, nine mildly, 14 moderately, and 13 severely. The aspects of life most affected were: sexual (13), psychological (11), physical (5), work (3), social (2), and family (2). Most of the problems encountered were related to infectivity. The availability of vaccines against HBV and of successful antiviral treatment have solved some of the problems, but it remains important for the medical profession to be aware of the multifaceted impact of the carriage of HBV.

Citing Articles

Does Alexithymia Predict the Psychiatric Comorbidity Among Healthy Carriers of Hepatitis B?.

Gunduz N, Timur O, Binici D, Erzincan E, Yosmaoglu A Alpha Psychiatry. 2025; 25(6):692-699.

PMID: 39830047 PMC: 11739906. DOI: 10.5152/alphapsychiatry.2024.21300.

The Association between Modifiable Lifestyle Behaviors and Depression among Asian Americans with Chronic Hepatitis B by Medication Status.

Zhu L, Lu W, Gamoso W, Tan Y, Johnson C, Ma G Brain Sci. 2022; 12(2).

PMID: 35203951 PMC: 8870133. DOI: 10.3390/brainsci12020188.

Wu X, Hong J, Zhou J, Sun Y, Li L, Xie W Hepatol Int. 2021; 15(6):1318-1327.

PMID: 34843068 DOI: 10.1007/s12072-021-10240-4.

Freeland C, Racho R, Kamischke M, Moraras K, Wang E, Cohen C J Patient Rep Outcomes. 2021; 5(1):121.

PMID: 34757456 PMC: 8581088. DOI: 10.1186/s41687-021-00398-8.

Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study.

Freeland C, Farrell S, Kumar P, Kamischke M, Jackson M, Bodor S BMC Public Health. 2021; 21(1):1004.

PMID: 34044808 PMC: 8161662. DOI: 10.1186/s12889-021-11093-0.

References

DUDLEY F, Scheuer P, Sherlock S . Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet. 1972; 2(7792):1388-93. DOI: 10.1016/s0140-6736(72)92963-7. View

Heathcote J, Cameron C, DANE D . Hepatitis-B antigen in saliva and semen. Lancet. 1974; 1(7847):71-3. DOI: 10.1016/s0140-6736(74)92289-2. View

VILLAREJOS V, Visona K, Gutierrez A, Rodriguez A . Role of saliva, urine and feces in the transmission of type B hepatitis. N Engl J Med. 1974; 291(26):1375-8. DOI: 10.1056/NEJM197412262912602. View

Feinman S, Krassnitski O, Sinclair J, Wrobel D, Berris B . Hepatitis B surface antigen in saliva of HB-SAg carriers. J Lab Clin Med. 1975; 85(6):1042-8. View

SZMUNESS W, Much I, Prince A, Hoofnagle J, CHERUBIN C, Harley E . On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med. 1975; 83(4):489-95. DOI: 10.7326/0003-4819-83-4-489. View

Bancroft W, Snitbhan R, Scott R, Tingpalapong M, Watson W, Tanticharoenyos P . Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis. 1977; 135(1):79-85. DOI: 10.1093/infdis/135.1.79. View

Alter H, Purcell R, Gerin J, London W, KAPLAN P, McAuliffe V . Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun. 1977; 16(3):928-33. PMC: 421053. DOI: 10.1128/iai.16.3.928-933.1977. View

Dietzman D, Harnisch J, RAY C, ALEXANDER E, Holmes K . Hepatitis B surface antigen (HBsAg) and antibody to HBsAg. Prevalence in homosexual and heterosexual men. JAMA. 1977; 238(24):2625-6. View

Scott R, Snitbhan R, Bancroft W, Alter H, Tingpalapong M . Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis. 1980; 142(1):67-71. DOI: 10.1093/infdis/142.1.67. View

10.

CROSNIER J, Jungers P, Courouce A, Laplanche A, Benhamou E, Degos F . Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff. Lancet. 1981; 1(8218):455-9. DOI: 10.1016/s0140-6736(81)91847-x. View

11.

Bassendine M, Chadwick R, Salmeron J, Shipton U, Thomas H, Sherlock S . Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. Gastroenterology. 1981; 80(5 pt 1):1016-22. View

12.

CROSNIER J, Jungers P, Courouce A, Laplanche A, Benhamou E, Degos F . Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients. Lancet. 1981; 1(8224):797-800. DOI: 10.1016/s0140-6736(81)92679-9. View

13.

Scullard G, Pollard R, Smith J, Sacks S, GREGORY P, ROBINSON W . Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. J Infect Dis. 1981; 143(6):772-83. DOI: 10.1093/infdis/143.6.772. View

14.

Scullard G, Andres L, Greenberg H, Smith J, Sawhney V, Neal E . Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside. Hepatology. 1981; 1(3):228-32. DOI: 10.1002/hep.1840010306. View

15.

SZMUNESS W, Stevens C, Zang E, Harley E, Kellner A . A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology. 1981; 1(5):377-85. DOI: 10.1002/hep.1840010502. View

16.

Beasley R, Hwang L, Lin C, Chien C . Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981; 2(8256):1129-33. DOI: 10.1016/s0140-6736(81)90585-7. View

17.

Viola L, Barrison I, Coleman J, Paradinas F, Fluker J, Evans B . Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain. Lancet. 1981; 2(8256):1156-9. DOI: 10.1016/s0140-6736(81)90600-0. View

18.

Berninger M, Hammer M, Hoyer B, Gerin J . An assay for the detection of the DNA genome of hepatitis B virus in serum. J Med Virol. 1982; 9(1):57-68. DOI: 10.1002/jmv.1890090109. View

19.

Schreeder M, THOMPSON S, Hadler S, Berquist K, Zaidi A, MAYNARD J . Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis. 1982; 146(1):7-15. DOI: 10.1093/infdis/146.1.7. View

20.

Weller I, Bassendine M, Craxi A, Fowler M, MONJARDINO J, Thomas H . Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP). Gut. 1982; 23(9):717-23. PMC: 1419747. DOI: 10.1136/gut.23.9.717. View